Q4 2023 · 13F-HR
NEA Management Company, LLCholdings as filed
Filed 2024-02-14 · accession 0001012975-24-000103
$1.50B
Reported value
44
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 22266M104 | COUR | COURSERA INC | $249.2M | 16.6% | 12,867,769 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $207.9M | 13.9% | 3,745,262 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $133.8M | 8.92% | 2,909,956 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $115.0M | 7.67% | 24,471,264 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $111.0M | 7.40% | 5,108,563 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $99.4M | 6.62% | 1,587,854 | Common | SOLE |
| 126638105 | CVRX | CVRX INC | $74.5M | 4.97% | 2,370,542 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $48.1M | 3.20% | 22,776,409 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $43.5M | 2.90% | 7,692,298 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $41.1M | 2.74% | 1,072,936 | Common | SOLE |
| 65345N106 | NN | NEXTNAV INC | $36.4M | 2.43% | 8,189,156 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $35.7M | 2.38% | 3,969,834 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $23.6M | 1.57% | 3,568,781 | Common | SOLE |
| 10920V404 | — | BRIGHT HEALTH GROUP INC | $19.9M | 1.32% | 2,726,917 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $18.8M | 1.25% | 3,850,275 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $18.2M | 1.21% | 1,250,001 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $17.9M | 1.19% | 1,960,169 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $16.8M | 1.12% | 6,147,260 | Common | SOLE |
| 98955G103 | — | ZEROFOX HLDGS INC | $15.7M | 1.05% | 18,068,513 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $15.2M | 1.02% | 11,370,376 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $14.5M | 0.96% | 15,838,009 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $13.5M | 0.90% | 17,079,778 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $12.6M | 0.84% | 14,986,793 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS INC | $12.5M | 0.83% | 4,448,757 | Common | SOLE |
| 90114C107 | TUYA | TUYA INC | $11.3M | 0.76% | 4,934,640 | Common | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $11.3M | 0.75% | 2,922,774 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $11.2M | 0.75% | 4,764,440 | Common | SOLE |
| 25058X105 | — | DESKTOP METAL INC | $10.8M | 0.72% | 14,407,594 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $10.4M | 0.69% | 2,437,689 | Common | SOLE |
| 15870P307 | CSBR | CHAMPIONS ONCOLOGY INC | $9.6M | 0.64% | 1,713,720 | Common | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $7.7M | 0.51% | 4,785,494 | Common | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $6.6M | 0.44% | 1,462,586 | Common | SOLE |
| 57055L206 | MRKR | MARKER THERAPEUTICS INC | $5.9M | 0.39% | 1,071,428 | Common | SOLE |
| 12430A102 | — | BUZZFEED INC | $3.8M | 0.26% | 15,333,892 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $3.6M | 0.24% | 2,382,286 | Common | SOLE |
| 81726A100 | — | SENTI BIOSCIENCES INC | $2.9M | 0.19% | 4,426,151 | Common | SOLE |
| N01045108 | — | AFFIMED NV | $2.8M | 0.18% | 4,426,488 | Common | SOLE |
| 75915K200 | — | REGULUS THERAPEUTICS INC | $2.5M | 0.17% | 1,945,579 | Common | SOLE |
| 628988107 | MYND | MYND AI INC | $1.8M | 0.12% | 23,642,711 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $1.3M | 0.09% | 430,252 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $1.1M | 0.07% | 570,050 | Common | SOLE |
| 96328L205 | 2CH | WHEELS UP EXPERIENCE INC | $364,009 | 0.02% | 106,126 | Common | SOLE |
| 868927104 | — | SURF AIR MOBILITY INC | $307,191 | 0.02% | 220,209 | Common | SOLE |
| 00654J206 | ADXN | ADDEX THERAPEUTICS LTD | $305,728 | 0.02% | 9,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.